AleAnna ROE 2022-2025 | ANNA

Current and historical return on equity (ROE) values for AleAnna (ANNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

AleAnna ROE - Return on Equity Historical Data
Date	TTM Net Income	Shareholder's Equity	Return on Equity
2025-09-30	$-0.01B	$0.06B	-15.38%
2025-06-30	$-0.01B	$0.05B	-32.88%
2025-03-31	$-0.06B	$0.05B	-244.44%
2024-12-31	$-0.17B	$0.05B	-1712.82%
2024-09-30	$-0.22B	$0.00B	540.74%
2024-06-30	$-0.22B	$0.00B	541.61%
2024-03-31	$-0.17B	$0.00B	437.74%
2023-12-31	$-0.06B	$-0.15B	143.03%
2023-09-30	$0.00B	$0.00B	-114.29%
2023-06-30	$0.00B	$0.00B	-88.89%
2023-03-31	$0.00B	$-0.01B	-52.17%
2022-12-31	$0.00B	$0.00B	-57.14%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.172B	$0.001B
AleAnna Inc. is an energy company dedicated to unlocking natural gas reserves and advancing renewable energy solutions to address the energy needs. AleAnna Inc., formerly known as Swiftmerge Acquisition Corp., is headquartered in Dallas, TX.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$94.091B	32.86
Takeda Pharmaceutical (TAK)	Japan	$55.653B	10.93
Zoetis (ZTS)	United States	$55.060B	19.71
BeOne Medicines - (ONC)	Switzerland	$37.834B	200.58
Daiichi Sankyo, - (DSNKY)	Japan	$36.049B	17.95
Sandoz Group AG (SDZNY)	Switzerland	$34.668B	0.00
United Therapeutics (UTHR)	United States	$20.452B	18.00
Merck (MKKGY)	Germany	$19.309B	11.90
Shionogi (SGIOY)	Japan	$17.686B	13.68
Neurocrine Biosciences (NBIX)	United States	$13.723B	32.93
IPSEN (IPSEY)	France	$13.491B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.455B	0.00
Orion OYJ (ORINY)	Finland	$11.502B	32.86
Madrigal Pharmaceuticals (MDGL)	United States	$11.122B	0.00
Summit Therapeutics (SMMT)	United States	$10.842B	0.00
Eisai (ESAIY)		$8.248B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.149B	17.10
Crinetics Pharmaceuticals (CRNX)	United States	$5.042B	0.00
Stevanato Group S.p.A (STVN)	Italy	$4.764B	26.66
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.642B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.461B	21.18
Indivior (INDV)	United States	$4.376B	17.86
Corcept Therapeutics (CORT)	United States	$4.282B	46.26
NewAmsterdam Pharma (NAMS)	Netherlands	$3.580B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.386B	0.00
Hypermarcas (HYPMY)	Brazil	$3.148B	21.61
Catalyst Pharmaceuticals (CPRX)	United States	$3.073B	9.80
Dyne Therapeutics (DYN)	United States	$2.679B	0.00
Soleno Therapeutics (SLNO)	United States	$2.273B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.105B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.050B	39.48
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.007B	23.78
Ocular Therapeutix (OCUL)	United States	$1.949B	0.00
Ardelyx (ARDX)	United States	$1.893B	0.00
Definium Therapeutics (DFTX)	United States	$1.796B	0.00
Enliven Therapeutics (ELVN)	United States	$1.672B	0.00
Harrow (HROW)	United States	$1.663B	102.04
Oruka Therapeutics (ORKA)	United States	$1.660B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.611B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.489B	7.37
Relay Therapeutics (RLAY)	United States	$1.413B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$1.397B	82.88
Xeris Biopharma Holdings (XERS)	United States	$1.221B	0.00
Evotec AG (EVO)	Germany	$1.215B	0.00
Savara (SVRA)	United States	$1.123B	0.00
Aktis Oncology (AKTS)	United States	$1.113B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.018B	0.00
Theravance Biopharma (TBPH)	United States	$1.005B	42.19
Cronos Group (CRON)	Canada	$0.958B	0.00
Xencor (XNCR)	United States	$0.865B	0.00
Esperion Therapeutics (ESPR)	United States	$0.837B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.814B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.804B	19.00
Nektar Therapeutics (NKTR)	United States	$0.775B	0.00
Bioventus (BVS)	United States	$0.679B	13.91
Rigel Pharmaceuticals (RIGL)	United States	$0.654B	5.84
Altimmune (ALT)	United States	$0.626B	0.00
ProKidney (PROK)	United States	$0.614B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.558B	0.00
Organogenesis (ORGO)	United States	$0.537B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.527B	0.00
Lyell Immunopharma (LYEL)	United States	$0.526B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.523B	0.00
Aquestive Therapeutics (AQST)	United States	$0.500B	0.00
Siga Technologies (SIGA)	United States	$0.498B	6.81
Nature's Sunshine Products (NATR)	United States	$0.463B	27.54
Elite Pharmaceuticals (ELTP)	United States	$0.451B	0.00
USANA Health Sciences (USNA)	United States	$0.396B	11.05
Aclaris Therapeutics (ACRS)	United States	$0.391B	0.00
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Protara Therapeutics (TARA)	United States	$0.363B	0.00
Cybin (HELP)	Canada	$0.343B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.327B	0.00
Larimar Therapeutics (LRMR)	United States	$0.291B	0.00
Avalo Therapeutics (AVTX)	United States	$0.290B	0.00
Journey Medical (DERM)	United States	$0.286B	0.00
Profound Medical (PROF)	Canada	$0.282B	0.00
Relmada Therapeutics (RLMD)	United States	$0.281B	0.00
OmniAb (OABI)	United States	$0.258B	0.00
Heron Therapeutics (HRTX)	United States	$0.253B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.247B	0.00
MediWound (MDWD)	Israel	$0.232B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.231B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.229B	0.00
Context Therapeutics (CNTX)	United States	$0.218B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.210B	0.00
Minerva Neurosciences (NERV)	United States	$0.203B	0.00
Galectin Therapeutics (GALT)	United States	$0.193B	0.00
Surrozen (SRZN)	United States	$0.189B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.146B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.145B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.139B	0.00
Avita Medical (RCEL)	United States	$0.129B	0.00
Prelude Therapeutics (PRLD)	United States	$0.128B	0.00
Korro Bio (KRRO)	United States	$0.123B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.119B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.118B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Vivani Medical (VANI)	United States	$0.115B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.107B	0.00
Incannex Healthcare (IXHL)	Australia	$0.102B	0.00
Champions Oncology (CSBR)	United States	$0.099B	41.95
Pyxis Oncology (PYXS)	United States	$0.095B	0.00
Cassava Sciences (SAVA)	United States	$0.094B	0.00
Assertio Holdings (ASRT)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.077B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Gain Therapeutics (GANX)	United States	$0.068B	0.00
Fractyl Health (GUTS)	United States	$0.065B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Dominari Holdings (DOMH)	United States	$0.064B	0.00
Rafael Holdings (RFL)	United States	$0.061B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.25
Acrivon Therapeutics (ACRV)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.057B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.056B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.055B	0.00
ElectroCore (ECOR)	United States	$0.052B	0.00
Lipocine (LPCN)	United States	$0.050B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.042B	0.00
Lite Strategy (LITS)	United States	$0.042B	0.00
Talphera (TLPH)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.034B	0.00
Plus Therapeutics (PSTV)	United States	$0.034B	0.00
SCYNEXIS (SCYX)	United States	$0.031B	0.00
Wellgistics Health (WGRX)	United States	$0.030B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Natural Alternatives (NAII)	United States	$0.025B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.020B	0.00
Klotho Neurosciences (KLTO)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Scienture Holdings (SCNX)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Inotiv (NOTV)	United States	$0.017B	0.00
Cosmos Health (COSM)	United States	$0.017B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Citius Pharmaceuticals (CTXR)	United States	$0.016B	0.00
Liminatus Pharma (LIMN)	United States	$0.015B	0.00
Vivos Therapeutics (VVOS)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Vyome Holdings (HIND)	United States	$0.012B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Ainos (AIMD)	United States	$0.011B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.011B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.006B	0.00
Heatwurx (PCSA)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
SciSparc (SPRC)	Israel	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00